Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines-Reference-Cited by-同舟云学术

Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines

Published:2020-02 Issue:2 Volume:20 Page:e76-e81
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Marcault Clemence,Venton Geoffroy,Gastaud Lauris,Mannone Lionel,Rey Jerome,D’Incan Evelyne,Saillard Colombe,Charbonnier Aude,Raynaud Sophie,Vey Norbert,Cluzeau Thomas^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference18 articles.

1. High-dose daunorubicin in older patients with acute myeloid leukemia;Löwenberg;N Engl J Med,2009

2. Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients;Clavio;J Exp Clin Cancer Res,2002

3. European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy;Burnett;J Clin Oncol,2010

4. Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors;Kantarjian;J Clin Oncol,2010

5. Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia;Kadia;Cancer,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and treatment of therapy-related acute myeloid leukemia;Critical Reviews in Oncology/Hematology;2022-03

2. Cytarabine/topotecan;Reactions Weekly;2020-03